3C
MED icon

361 Capital’s Medifast MED Stock Holding History

361 Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,518
Closed -$1.3M – 373
2019
Q3 		$1.3M Sell
12,518
-284
-2% -$30.5K 0.24% 182
2019
Q2 		$1.64M Sell
12,802
-906
-7% -$126K 0.29% 172
2019
Q1 		$1.75M Buy
13,708
+1,108
+9% +$141K 0.3% 168
2018
Q4 		$1.57M Buy
12,600
+5,295
+72% +$906K 0.32% 172
2018
Q3 		$1.62M Sell
7,305
-2,330
-24% -$472K 0.35% 154
2018
Q2 		$1.54M Sell
9,635
-6,585
-41% -$842K 0.35% 168
2018
Q1 		$1.52M Sell
16,220
-3,312
-17% -$247K 0.38% 112
2017
Q4 		$1.36M Buy
+19,532
New +$1.3M 0.34% 160

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return